Sunnyvale research center named part of nationwide Parkinson's study
 
Published Monday, October 18, 2010 4:00 am

By John Dugan
jdugan@community-newspapers.com
Posted: 10/14/2010 08:02:06 PM PDT

Sunnyvale will soon be the California epicenter of one of the largest Parkinson's disease research studies, as the Michael J. Fox Foundation has named the Parkinson's Institute and Clinical Center one of 18 research centers in its Parkinson's Progression Markers Initiative (PPMI). The Sunnyvale site is the only one chosen for the study in California, and one of three on the West Coast.

The $40 million, five-year study sponsored by the Fox Foundation founded by actor Michael J. Fox, who has Parkinson's disease, will attempt to identify biomarkers of the disease in newly diagnosed patients. The Parkinson's Institute will study 20 patients and 10 control subjects over the next five years, and will team with El Camino Hospital for state-of-the-art neuroimaging services.

"To date, we don't have any drug that will slow or stop the progression of this disease in patients," Parkinson's Institute director of clinical research Dr. Caroline Tanner said. "We desperately need something that will more precisely allow us to measure disease progression. This is the first study that systematically sets out to identify a biomarker for Parkinson's."  Read More


Send this page to a friend

Show Other Stories

675 Almanor Avenue | Sunnyvale, CA 94085
408.734.2800 main | 408.734.8455 fax (Main) | 408.734.9208 fax (Clinic Secure)